Filing metadata

Accession number
0001328143-21-000063
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Jun 08, 2021
Reporting period
Jun 07, 2021
Description
Insider transaction

Explore SEC Filings Hub